Skip to main content
رجوع
ADPT logo

Adaptive Biotechnologies Corporation

جودة البيانات: 100%
ADPT
NASDAQ Healthcare Biotechnology
KWD 13.66
▲ KWD 0.08 (0.59%)
القيمة السوقية: 2.10B
نطاق اليوم
KWD 13.55 KWD 14.12
نطاق 52 أسبوعًا
KWD 6.68 KWD 20.76
حجم التداول
1,228,656
متوسط 50 يوم / 200 يوم
KWD 16.24 / KWD 14.47
الإغلاق السابق
KWD 13.58

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -35.4 0.4
P/B 9.6 2.9
ROE % -28.2 3.8
Net Margin % -21.5 3.9
Rev Growth 5Y % 15.7 10.0
D/E 1.3 0.2

السعر المستهدف للمحللين

Hold
KWD 21.250 +55.6%
Low: KWD 21.000 High: KWD 22.000
ربحية السهم المستقبلية
-KWD 0.484
الإيرادات المقدّرة
280 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 -KWD 0.010
-KWD 0.010 – -KWD 0.010
640 M 2
FY2029 KWD 0.085
KWD 0.083 – KWD 0.087
510 M 2
FY2028 -KWD 0.055
-KWD 0.288 – KWD 0.060
420 M 4

النقاط الرئيسية

Revenue grew 15.74% annually over 5 years — strong growth
Negative free cash flow of -48.95M
PEG of 0.65 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 39.03%
Capital efficient — spends only 1.07% of revenue on capex

النمو

Revenue Growth (5Y)
15.74%
Revenue (1Y)54.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-28.23%
ROIC-8.58%
Net Margin-21.48%
Op. Margin-20.62%

الأمان

Debt / Equity
1.28
Current Ratio3.34
Interest Coverage-4.85

التقييم

P/E Ratio
-35.35
P/B Ratio9.61
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 54.77% Revenue Growth (3Y) 27.54%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.74% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 276.98M Net Income (TTM) -59.50M
ROE -28.23% ROA -11.60%
Gross Margin 74.24% Operating Margin -20.62%
Net Margin -21.48% Free Cash Flow (TTM) -48.95M
ROIC -8.58% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.28 Current Ratio 3.34
Interest Coverage -4.85 Dividend Yield 0.00%
Valuation
P/E Ratio -35.35 P/B Ratio 9.61
P/S Ratio 7.59 PEG Ratio 0.65
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 2.10B Enterprise Value 2.31B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 276.98M 178.96M 170.28M 185.31M 154.34M
Net Income -59.50M -159.49M -225.25M -200.19M -207.28M
EPS (Diluted) -0.39 -1.08 -1.56 -1.00 -1.46
Gross Profit 205.62M 106.88M 94.72M 127.40M 105.04M
Operating Income -57.12M -162.55M -227.04M -200.19M -208.97M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 512.74M 539.38M 661.13M 856.62M 923.34M
Total Liabilities 287.74M 336.89M 352.86M 392.52M 319.24M
Shareholders' Equity 218.79M 202.71M 308.40M 464.17M 603.99M
Total Debt 280.58M 89.39M 98.77M 108.00M 111.74M
Cash & Equivalents 70.50M 47.92M 65.06M 90.03M 139.07M
Current Assets 300.19M 283.75M 410.19M 562.15M 402.75M
Current Liabilities 89.92M 98.05M 88.02M 109.79M 113.81M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#63 of 146
48

النشاط الأخير

دخل Full Throttle
Mar 24, 2026